Advertisement

August 15, 2018

AngioDynamics Acquires Surgical Specialties' BioSentry System

August 15, 2018—AngioDynamics, Inc. announced the acquisition of the BioSentry tract sealant system technology from Surgical Specialties, LLC, a medical device company headquartered in Westwood, Massachusetts. Additionally, Surgical Specialties’ 12-person commercial organization will join AngioDynamics' Oncology business.

According to the company, the commercialized BioSentry product minimizes the occurrence of pneumothorax (PTX), which is a complication of CT-guided percutaneous lung biopsy. The technology's hydrogel plug prevents air leakage during the biopsy procedure to mitigate the risk of PTX.

The BioSentry system was approved by the FDA in December 2012 and commercially launched in 2013. It has also received European CE Mark approval.

Advertisement


August 16, 2018

FDA Clears Boston Scientific's Savion Guidewires for BTK Interventions

August 15, 2018

Three-Year Results Published From STROLL Study of Cordis' S.M.A.R.T. Stent